SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-008103
Filing Date
2021-07-21
Accepted
2021-07-21 16:05:43
Documents
2
Period of Report
2021-07-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_july2021.htm 8-K 32547
2 LETTER FROM OUM & CO., LLP DATED JULY 20, 2021 vtgn_ex161.htm EX-16.1 4280
  Complete submission text file 0001654954-21-008103.txt   38046
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 211104560
SIC: 2834 Pharmaceutical Preparations